188 related articles for article (PubMed ID: 15375513)
1. Molecular analysis of PinX1 in human hepatocellular carcinoma.
Oh BK; Chae KJ; Park C; Park YN
Oncol Rep; 2004 Oct; 12(4):861-6. PubMed ID: 15375513
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
3. Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length.
Song H; Li Y; Chen G; Xing Z; Zhao J; Yokoyama KK; Li T; Zhao M
Biochem Biophys Res Commun; 2004 Apr; 316(4):1116-23. PubMed ID: 15044100
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
Kanai Y; Hui AM; Sun L; Ushijima S; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1999 Mar; 29(3):703-9. PubMed ID: 10051471
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
[TBL] [Abstract][Full Text] [Related]
7. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
[TBL] [Abstract][Full Text] [Related]
8. C-terminal amino acids 290-328 of LPTS/PinX1 confer telomerase inhibition.
Chen G; Da L; Xu Y; Xu M; Song L; Li T; Zhao M
Biochem Biophys Res Commun; 2010 Aug; 398(4):683-9. PubMed ID: 20620128
[TBL] [Abstract][Full Text] [Related]
9. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
10. Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.
Zuo J; Wang DH; Zhang YJ; Liu L; Liu FL; Liu W
Oncol Rep; 2013 Oct; 30(4):1823-31. PubMed ID: 23912465
[TBL] [Abstract][Full Text] [Related]
11. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
Lee JE; Oh BK; Choi J; Park YN
Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
[TBL] [Abstract][Full Text] [Related]
12. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; CalabrĂ² A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of PinX1 in medulloblastomas.
Chang Q; Pang JC; Li J; Hu L; Kong X; Ng HK
Int J Cancer; 2004 Mar; 109(2):309-14. PubMed ID: 14750185
[TBL] [Abstract][Full Text] [Related]
14. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
15. Telomere length variation and maintenance in hepatocarcinogenesis.
Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; Kawai H; Mita Y; Aoyagi Y
Cancer; 2003 Jul; 98(1):110-8. PubMed ID: 12833463
[TBL] [Abstract][Full Text] [Related]
16. Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.
Zhang B; Bai YX; Ma HH; Feng F; Jin R; Wang ZL; Lin J; Sun SP; Yang P; Wang XX; Huang PT; Huang CF; Peng Y; Chen YC; Kung HF; Huang JJ
Cancer Res; 2009 Jan; 69(1):75-83. PubMed ID: 19117989
[TBL] [Abstract][Full Text] [Related]
17. Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma.
Akiyama Y; Maesawa C; Wada K; Fujisawa K; Itabashi T; Noda Y; Honda T; Sato N; Ishida K; Takagane A; Saito K; Masuda T
Oncol Rep; 2004 Apr; 11(4):871-4. PubMed ID: 15010887
[TBL] [Abstract][Full Text] [Related]
18. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
19. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
[TBL] [Abstract][Full Text] [Related]
20. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]